AnalystsCerena ChenCerena Chen's Stock Forecasts
AnalystsCerena Chen
Analyst Ranking
Top 38%
#1915 out of 5087 analysts
Average Return
+35.42%
Win Rate
100%5 out of 5
Risk vs Reward
Poor
Good
Cerena Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Metsera IncMTSR | +112.97% | $29.60 | $63.04 | 2025-06-20 - 2025-10-31 | Strong Buy |
Axsome Therapeutics IncAXSM | +37.72% | $89.65 | $123.47 | 2024-09-03 - 2025-09-02 | Strong Buy |
Axsome Therapeutics IncAXSM | +20.35% | $112.16 | $134.99 | 2025-05-06 - 2025-10-31 | Strong Buy |
Amphastar Pharmaceuticals IncAMPH | +3.45% | $24.65 | $25.50 | 2025-05-08 - 2025-10-31 | Strong Buy |
Axsome Therapeutics IncAXSM | +2.61% | $131.55 | $134.99 | 2025-02-12 - 2025-10-31 | Strong Buy |
Cerena Chen Analyst Color
Get additional color on Cerena Chen's coverage of popular stocks
Cerena Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Strategy IncMSTR | 1 | Hold | $54.00 | -79.96% | Downgrades | a month ago |
Metsera IncMTSR | 1 | Strong Buy | $65.00 | +3.11% | Initiates Coverage On | 4 months ago |
Amphastar Pharmaceuticals IncAMPH | 1 | Strong Buy | $35.00 | +37.25% | Maintains | 6 months ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $165.00 | +22.23% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.